DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: A mutational signature in gastric cancer suggests therapeutic strategies

Abstract

Targeting defects in the DNA repair machinery of neoplastic cells, for example, those due to inactivating BRCA1 and/or BRCA2 mutations, has been used for developing new therapies in certain types of breast, ovarian and pancreatic cancers. Recently, a mutational signature was associated with failure of double-strand DNA break repair by homologous recombination based on its high mutational burden in samples harbouring BRCA1 or BRCA2 mutations. In pancreatic cancer, all responders to platinum therapy exhibit this mutational signature including a sample that lacked any defects in BRCA1 or BRCA2. Here, we examine 10,250 cancer genomes across 36 types of cancer and demonstrate that, in addition to breast, ovarian and pancreatic cancers, gastric cancer is another cancer type that exhibits this mutational signature. Furthermore, our results suggest that 7–12% of gastric cancers have defective double-strand DNA break repair by homologous recombination and may benefit from either platinum therapy or PARP inhibitors.

Authors:
ORCiD logo [1];  [2];  [3];  [3];  [4]
  1. Los Alamos National Lab. (LANL), Los Alamos, NM (United States); Wellcome Trust Sanger Institute, Hinxton (United Kingdom)
  2. Wellcome Trust Sanger Institute, Hinxton (United Kingdom); Addenbrooke's Hospital National Health Service (NHS) Trust, Cambridge (United Kingdom)
  3. The Univ. of Hong Kong, Queen Mary Hospital, Pokfulam (Hong Kong)
  4. Wellcome Trust Sanger Institute, Hinxton (United Kingdom)
Publication Date:
Research Org.:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1236756
Report Number(s):
LA-UR-15-24068
Journal ID: ISSN 2041-1723; ncomms9683
Grant/Contract Number:  
AC52-06NA25396
Resource Type:
Accepted Manuscript
Journal Name:
Nature Communications
Additional Journal Information:
Journal Volume: 6; Journal ID: ISSN 2041-1723
Publisher:
Nature Publishing Group
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; biological sciences; cancer; genetics; medical research

Citation Formats

Alexandrov, Ludmil B., Nik-Zainal, Serena, Siu, Hoi Cheong, Leung, Suet Yi, and Stratton, Michael R. A mutational signature in gastric cancer suggests therapeutic strategies. United States: N. p., 2015. Web. doi:10.1038/ncomms9683.
Alexandrov, Ludmil B., Nik-Zainal, Serena, Siu, Hoi Cheong, Leung, Suet Yi, & Stratton, Michael R. A mutational signature in gastric cancer suggests therapeutic strategies. United States. https://doi.org/10.1038/ncomms9683
Alexandrov, Ludmil B., Nik-Zainal, Serena, Siu, Hoi Cheong, Leung, Suet Yi, and Stratton, Michael R. Thu . "A mutational signature in gastric cancer suggests therapeutic strategies". United States. https://doi.org/10.1038/ncomms9683. https://www.osti.gov/servlets/purl/1236756.
@article{osti_1236756,
title = {A mutational signature in gastric cancer suggests therapeutic strategies},
author = {Alexandrov, Ludmil B. and Nik-Zainal, Serena and Siu, Hoi Cheong and Leung, Suet Yi and Stratton, Michael R.},
abstractNote = {Targeting defects in the DNA repair machinery of neoplastic cells, for example, those due to inactivating BRCA1 and/or BRCA2 mutations, has been used for developing new therapies in certain types of breast, ovarian and pancreatic cancers. Recently, a mutational signature was associated with failure of double-strand DNA break repair by homologous recombination based on its high mutational burden in samples harbouring BRCA1 or BRCA2 mutations. In pancreatic cancer, all responders to platinum therapy exhibit this mutational signature including a sample that lacked any defects in BRCA1 or BRCA2. Here, we examine 10,250 cancer genomes across 36 types of cancer and demonstrate that, in addition to breast, ovarian and pancreatic cancers, gastric cancer is another cancer type that exhibits this mutational signature. Furthermore, our results suggest that 7–12% of gastric cancers have defective double-strand DNA break repair by homologous recombination and may benefit from either platinum therapy or PARP inhibitors.},
doi = {10.1038/ncomms9683},
journal = {Nature Communications},
number = ,
volume = 6,
place = {United States},
year = {Thu Oct 29 00:00:00 EDT 2015},
month = {Thu Oct 29 00:00:00 EDT 2015}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 123 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
journal, March 1998

  • Ford, D.; Easton, D. F.; Stratton, M.
  • The American Journal of Human Genetics, Vol. 62, Issue 3
  • DOI: 10.1086/301749

Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
journal, October 2003


Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian Cancer
journal, March 2001

  • Risch, Harvey A.; McLaughlin, John R.; Cole, David E. C.
  • The American Journal of Human Genetics, Vol. 68, Issue 3
  • DOI: 10.1086/318787

Role of BRCA1 and BRCA2 mutations in pancreatic cancer
journal, May 2007


Somatic mutations in the BRCA1 gene in sporadic ovarian tumours
journal, April 1995

  • Merajver, Sofia D.; Pham, Trinh M.; Caduff, Rosemarie F.
  • Nature Genetics, Vol. 9, Issue 4
  • DOI: 10.1038/ng0495-439

Mutation analysis in the BRCA2 gene in primary breast cancers
journal, June 1996

  • Miki, Yoshio; Katagiri, Toyomasa; Kasumi, Fujio
  • Nature Genetics, Vol. 13, Issue 2
  • DOI: 10.1038/ng0696-245

Sensing and repairing DNA double-strand breaks
journal, May 2002


Mutational Processes Molding the Genomes of 21 Breast Cancers
journal, May 2012


Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer
journal, March 2006


High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
journal, October 2008

  • Rottenberg, S.; Jaspers, J. E.; Kersbergen, A.
  • Proceedings of the National Academy of Sciences, Vol. 105, Issue 44
  • DOI: 10.1073/pnas.0806092105

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
journal, April 2005

  • Farmer, Hannah; McCabe, Nuala; Lord, Christopher J.
  • Nature, Vol. 434, Issue 7035
  • DOI: 10.1038/nature03445

Signatures of mutational processes in human cancer
journal, August 2013

  • Alexandrov, Ludmil B.; Nik-Zainal, Serena; Wedge, David C.
  • Nature, Vol. 500, Issue 7463
  • DOI: 10.1038/nature12477

Mutational signatures: the patterns of somatic mutations hidden in cancer genomes
journal, February 2014

  • Alexandrov, Ludmil B.; Stratton, Michael R.
  • Current Opinion in Genetics & Development, Vol. 24
  • DOI: 10.1016/j.gde.2013.11.014

Mechanisms underlying mutational signatures in human cancers
journal, July 2014

  • Helleday, Thomas; Eshtad, Saeed; Nik-Zainal, Serena
  • Nature Reviews Genetics, Vol. 15, Issue 9
  • DOI: 10.1038/nrg3729

Deciphering Signatures of Mutational Processes Operative in Human Cancer
journal, January 2013


Whole genomes redefine the mutational landscape of pancreatic cancer
journal, February 2015

  • Waddell, Nicola; Pajic, Marina; Patch, Ann-Marie
  • Nature, Vol. 518, Issue 7540
  • DOI: 10.1038/nature14169

Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
journal, May 2014

  • Wang, Kai; Yuen, Siu Tsan; Xu, Jiangchun
  • Nature Genetics, Vol. 46, Issue 6
  • DOI: 10.1038/ng.2983

Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes
journal, April 2012

  • Zang, Zhi Jiang; Cutcutache, Ioana; Poon, Song Ling
  • Nature Genetics, Vol. 44, Issue 5
  • DOI: 10.1038/ng.2246

Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
journal, October 2011

  • Wang, Kai; Kan, Junsuo; Yuen, Siu Tsan
  • Nature Genetics, Vol. 43, Issue 12
  • DOI: 10.1038/ng.982

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
journal, June 2010

  • Ferlay, Jacques; Shin, Hai-Rim; Bray, Freddie
  • International Journal of Cancer, Vol. 127, Issue 12
  • DOI: 10.1002/ijc.25516

dbSNP: the NCBI database of genetic variation
journal, January 2001


Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants
journal, November 2012

  • Fu, Wenqing; O’Connor, Timothy D.; Jun, Goo
  • Nature, Vol. 493, Issue 7431
  • DOI: 10.1038/nature11690

The UCSC Genome Browser database: extensions and updates 2011
journal, November 2011

  • Dreszer, T. R.; Karolchik, D.; Zweig, A. S.
  • Nucleic Acids Research, Vol. 40, Issue D1
  • DOI: 10.1093/nar/gkr1055

Genome sequencing of normal cells reveals developmental lineages and mutational processes
journal, June 2014

  • Behjati, Sam; Huch, Meritxell; van Boxtel, Ruben
  • Nature, Vol. 513, Issue 7518
  • DOI: 10.1038/nature13448

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
journal, January 2014

  • Bolli, Niccolo; Avet-Loiseau, Hervé; Wedge, David C.
  • Nature Communications, Vol. 5, Issue 1
  • DOI: 10.1038/ncomms3997

Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer
journal, October 2014

  • Ju, Young Seok; Alexandrov, Ludmil B.; Gerstung, Moritz
  • eLife, Vol. 3
  • DOI: 10.7554/eLife.02935

Transmissible Dog Cancer Genome Reveals the Origin and History of an Ancient Cell Lineage
journal, January 2014


Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer
journal, April 2014

  • Nik-Zainal, Serena; Wedge, David C.; Alexandrov, Ludmil B.
  • Nature Genetics, Vol. 46, Issue 5
  • DOI: 10.1038/ng.2955

Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
journal, February 2014

  • Gerlinger, Marco; Horswell, Stuart; Larkin, James
  • Nature Genetics, Vol. 46, Issue 3
  • DOI: 10.1038/ng.2891

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma.
text, January 2014

  • Bolli, Niccolo; Avet-Loiseau, Hervé; Wedge, David C.
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.33452

Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer.
text, January 2014

  • Nik-Zainal, Serena; Wedge, David C.; Alexandrov, Ludmil B.
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.42271

Deciphering signatures of mutational processes operative in human cancer.
text, January 2013

  • Alexandrov, Ludmil B.; Nik-Zainal Abidin, Serena; Wedge, David C.
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.60112

Comprehensive molecular characterization of gastric adenocarcinoma
text, January 2014

  • Reanne, Bowlby,; Amaro, Taylor-Weiner,; Andy, Chu,
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/eyft-ty56

An integrated map of genetic variation from 1,092 human genomes
text, January 2012

  • Yun, Li,
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/rsw4-ne53

Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer.
text, January 2014

  • Ju, Young Seok; Alexandrov, Ludmil B.; Gerstung, Moritz
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.31876

Signatures of mutational processes in human cancer.
text, January 2013

  • Alexandrov, Ludmil B.; Nik-Zainal Abidin, Serena; Wedge, David C.
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.31889

Deciphering Signatures of Mutational Processes Operative in Human Cancer
journal, January 2013


Mutational signatures: the patterns of somatic mutations hidden in cancer genomes
journal, February 2014

  • Alexandrov, Ludmil B.; Stratton, Michael R.
  • Current Opinion in Genetics & Development, Vol. 24
  • DOI: 10.1016/j.gde.2013.11.014

Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants
journal, November 2012

  • Fu, Wenqing; O’Connor, Timothy D.; Jun, Goo
  • Nature, Vol. 493, Issue 7431
  • DOI: 10.1038/nature11690

Signatures of mutational processes in human cancer
journal, August 2013

  • Alexandrov, Ludmil B.; Nik-Zainal, Serena; Wedge, David C.
  • Nature, Vol. 500, Issue 7463
  • DOI: 10.1038/nature12477

Genome sequencing of normal cells reveals developmental lineages and mutational processes
journal, June 2014

  • Behjati, Sam; Huch, Meritxell; van Boxtel, Ruben
  • Nature, Vol. 513, Issue 7518
  • DOI: 10.1038/nature13448

Whole genomes redefine the mutational landscape of pancreatic cancer
journal, February 2015

  • Waddell, Nicola; Pajic, Marina; Patch, Ann-Marie
  • Nature, Vol. 518, Issue 7540
  • DOI: 10.1038/nature14169

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
journal, January 2014

  • Bolli, Niccolo; Avet-Loiseau, Hervé; Wedge, David C.
  • Nature Communications, Vol. 5, Issue 1
  • DOI: 10.1038/ncomms3997

Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
journal, February 2014

  • Gerlinger, Marco; Horswell, Stuart; Larkin, James
  • Nature Genetics, Vol. 46, Issue 3
  • DOI: 10.1038/ng.2891

Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer
journal, April 2014

  • Nik-Zainal, Serena; Wedge, David C.; Alexandrov, Ludmil B.
  • Nature Genetics, Vol. 46, Issue 5
  • DOI: 10.1038/ng.2955

Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
journal, October 2011

  • Wang, Kai; Kan, Junsuo; Yuen, Siu Tsan
  • Nature Genetics, Vol. 43, Issue 12
  • DOI: 10.1038/ng.982

Somatic mutations in the BRCA1 gene in sporadic ovarian tumours
journal, April 1995

  • Merajver, Sofia D.; Pham, Trinh M.; Caduff, Rosemarie F.
  • Nature Genetics, Vol. 9, Issue 4
  • DOI: 10.1038/ng0495-439

Mechanisms underlying mutational signatures in human cancers
journal, July 2014

  • Helleday, Thomas; Eshtad, Saeed; Nik-Zainal, Serena
  • Nature Reviews Genetics, Vol. 15, Issue 9
  • DOI: 10.1038/nrg3729

Recurrent Somatic Mutations in Human Gastric Cancers Identified by Whole Exome Sequencing
journal, November 2012


High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
journal, October 2008

  • Rottenberg, S.; Jaspers, J. E.; Kersbergen, A.
  • Proceedings of the National Academy of Sciences, Vol. 105, Issue 44
  • DOI: 10.1073/pnas.0806092105

Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian Cancer
journal, March 2001

  • Risch, Harvey A.; McLaughlin, John R.; Cole, David E. C.
  • The American Journal of Human Genetics, Vol. 68, Issue 3
  • DOI: 10.1086/318787

Sensing and repairing DNA double-strand breaks
journal, May 2002


The UCSC Genome Browser database: extensions and updates 2011
journal, November 2011

  • Dreszer, T. R.; Karolchik, D.; Zweig, A. S.
  • Nucleic Acids Research, Vol. 40, Issue D1
  • DOI: 10.1093/nar/gkr1055

Role of BRCA1 and BRCA2 mutations in pancreatic cancer
journal, May 2007


Works referencing / citing this record:

Tumor mutation burden and recurrent tumors in hereditary lung cancer
journal, April 2019

  • Hsu, Yi‐Chiung; Chang, Ya‐Hsuan; Chang, Gee‐Chen
  • Cancer Medicine, Vol. 8, Issue 5
  • DOI: 10.1002/cam4.2120

Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas: Mutational signature associated with MUTYH deficiency in cancers
journal, March 2017

  • Pilati, Camilla; Shinde, Jayendra; Alexandrov, Ludmil B.
  • The Journal of Pathology, Vol. 242, Issue 1
  • DOI: 10.1002/path.4880

Personalised Treatment in Gastric Cancer: Myth or Reality?
journal, May 2016

  • Tarazona, Noelia; Gambardella, Valentina; Huerta, Marisol
  • Current Oncology Reports, Vol. 18, Issue 7
  • DOI: 10.1007/s11912-016-0525-x

Precision oncology in the age of integrative genomics
journal, January 2018

  • Kumar-Sinha, Chandan; Chinnaiyan, Arul M.
  • Nature Biotechnology, Vol. 36, Issue 1
  • DOI: 10.1038/nbt.4017

Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance
journal, September 2016

  • Secrier, Maria; Li, Xiaodun; de Silva, Nadeera
  • Nature Genetics, Vol. 48, Issue 10
  • DOI: 10.1038/ng.3659

HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
journal, March 2017

  • Davies, Helen; Glodzik, Dominik; Morganella, Sandro
  • Nature Medicine, Vol. 23, Issue 4
  • DOI: 10.1038/nm.4292

BRCAness revisited
journal, January 2016

  • Lord, Christopher J.; Ashworth, Alan
  • Nature Reviews Cancer, Vol. 16, Issue 2
  • DOI: 10.1038/nrc.2015.21

Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes
journal, October 2017


Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
journal, November 2017


Mutation hotspots at CTCF binding sites coupled to chromosomal instability in gastrointestinal cancers
journal, April 2018


Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer
journal, November 2018


The genetic landscape of 5T models for multiple myeloma
journal, October 2018


Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer
journal, March 2019


Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes
journal, April 2020


Targeting deficient DNA damage repair in gastric cancer
journal, August 2016


Computational approaches for discovery of mutational signatures in cancer
journal, July 2017

  • Baez-Ortega, Adrian; Gori, Kevin
  • Briefings in Bioinformatics, Vol. 20, Issue 1
  • DOI: 10.1093/bib/bbx082

Understanding mutagenesis through delineation of mutational signatures in human cancer
journal, May 2016


Exploring background mutational processes to decipher cancer genetic heterogeneity
journal, May 2017

  • Goncearenco, Alexander; Rager, Stephanie L.; Li, Minghui
  • Nucleic Acids Research, Vol. 45, Issue W1
  • DOI: 10.1093/nar/gkx367

SigLASSO: a LASSO approach jointly optimizing sampling likelihood and cancer mutation signatures
posted_content, May 2018

  • Li, Shantao; Crawford, Forrest W.; Gerstein, Mark B.
  • Nature Communications
  • DOI: 10.1101/366740

Genomic aberration based molecular signatures efficiently characterize homologous recombination deficiency in prostate cancer
posted_content, June 2019

  • Sztupinszki, Zsofia; Diossy, Miklos; Krzystanek, Marcin
  • BioRxiv
  • DOI: 10.1101/681114

Mutational signatures associated with tobacco smoking in human cancer
journal, November 2016


Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
journal, March 2019


Portrait of a cancer: mutational signature analyses for cancer diagnostics
journal, May 2019


Actionable gene-based classification toward precision medicine in gastric cancer
journal, October 2017


FIREVAT: finding reliable variants without artifacts in human cancer samples using etiologically relevant mutational signatures
journal, December 2019


Persistent double strand break accumulation does not precede cell death in an Olaparib-sensitive BRCA-deficient colorectal cancer cell model
journal, January 2020

  • Paviolo, Natalia Soledad; Vega, María Belén de la; Pansa, María Florencia
  • Genetics and Molecular Biology, Vol. 43, Issue 1 suppl 1
  • DOI: 10.1590/1678-4685-gmb-2019-0070

Mutational signatures associated with tobacco smoking in human cancer
posted_content, May 2016

  • Alexandrov, Ludmil B.; Ju, Young Seok; Haase, Kerstin
  • bioRxiv
  • DOI: 10.1101/051417

Computational approaches for discovery of mutational signatures in cancer
posted_content, June 2017


HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.
text, January 2017

  • Davies, Helen; Glodzik, Dominik; Morganella, Sandro
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.61944

Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance
text, January 2016

  • Secrier, Maria; Li, Xiaodun; De, Silva Nadeera
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.818

Computational approaches for discovery of mutational signatures in cancer.
text, January 2019

  • Baez-Ortega, Adrian; Gori, Kevin
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.11113

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma.
text, January 2019

  • Turkington, Richard C.; Knight, Laura A.; Blayney, Jaine K.
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.44131

Tumor mutation burden and recurrent tumors in hereditary lung cancer
journal, April 2019

  • Hsu, Yi‐Chiung; Chang, Ya‐Hsuan; Chang, Gee‐Chen
  • Cancer Medicine, Vol. 8, Issue 5
  • DOI: 10.1002/cam4.2120

Base changes in tumour DNA have the power to reveal the causes and evolution of cancer
journal, June 2016

  • Hollstein, M.; Alexandrov, L. B.; Wild, C. P.
  • Oncogene, Vol. 36, Issue 2
  • DOI: 10.1038/onc.2016.192

Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes
journal, October 2017


Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
journal, November 2017


Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer
journal, November 2018


The genetic landscape of 5T models for multiple myeloma
journal, October 2018


Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer
journal, March 2019


A proteogenomic approach for protein-level evidence of genomic variants in cancer cells
journal, October 2016

  • Yeom, Jeonghun; Kabir, Mohammad Humayun; Lim, Byungho
  • Scientific Reports, Vol. 6, Issue 1
  • DOI: 10.1038/srep35305

Exploring background mutational processes to decipher cancer genetic heterogeneity
journal, May 2017

  • Goncearenco, Alexander; Rager, Stephanie L.; Li, Minghui
  • Nucleic Acids Research, Vol. 45, Issue W1
  • DOI: 10.1093/nar/gkx367

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
journal, March 2019


The evolving immunotherapeutic landscape in advanced oesophagogastric cancer
journal, January 2018

  • Flynn, Michael; Young, Kate; Cunningham, David
  • Therapeutic Advances in Medical Oncology, Vol. 10
  • DOI: 10.1177/1758835918786228

Portrait of a cancer: mutational signature analyses for cancer diagnostics
journal, May 2019


Actionable gene-based classification toward precision medicine in gastric cancer
journal, October 2017


FIREVAT: finding reliable variants without artifacts in human cancer samples using etiologically relevant mutational signatures
journal, December 2019


The Origins and Vulnerabilities of Two Transmissible Cancers in Tasmanian Devils.
journalarticle, January 2018

  • Stammnitz, Maximilian R.; Coorens, Tim HH; Gori, Kevin C.
  • Elsevier BV
  • DOI: 10.17863/cam.21016

Platelet distribution width correlates with prognosis of gastric cancer
journal, February 2017


Comprehensive analysis of a novel four-lncRNA signature as a prognostic biomarker for human gastric cancer
journal, August 2017


The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles
journal, November 2017


Somatic genome alterations in relation to age in lung squamous cell carcinoma
journal, August 2018


Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancer
journal, September 2016

  • Wu, Han; Xian, Yun; Zhang, Shu
  • OncoTargets and Therapy, Vol. Volume 9
  • DOI: 10.2147/ott.s105787

The effects of BRCA1 expression on the chemosensitivity of gastric cancer cells to platinum agents
journal, March 2019